Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Breast Neoplasms and ROS1[original query] |
---|
The frequency and clinical impact of HER2 alterations in lung adenocarcinoma. PloS one 2017 12 (2): e0171280. Kim Eun Kyung, Kim Kyung A, Lee Chang Young, Shim Hyo S |
[Exploratory study of circulating tumor DNA detection in early breast cancer: an analysis of 75 next-generation sequencing results]. Zhonghua wai ke za zhi [Chinese journal of surgery] 2017 Nov 55 (11): 847-852. Zhou B, Xin L, Xu L, Liu Y H, Zhang M M, Jing R L, Liang X Y, Cao S |
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer. Breast cancer research : BCR 2018 Aug 20 (1): 88. Liang Xu, Vacher Sophie, Boulai Anais, Bernard Virginie, Baulande Sylvain, Bohec Mylene, Bièche Ivan, Lerebours Florence, Callens Céli |
LobSig is a multigene predictor of outcome in invasive lobular carcinoma. NPJ breast cancer 2019 7 5 18. McCart Reed Amy E, Lal Samir, Kutasovic Jamie R, Wockner Leesa, Robertson Alan, de Luca Xavier M, Kalita-de Croft Priyakshi, Dalley Andrew J, Coorey Craig P, Kuo Luyu, Ferguson Kaltin, Niland Colleen, Miller Gregory, Johnson Julie, Reid Lynne E, Males Renique, Saunus Jodi M, Chenevix-Trench Georgia, Coin Lachlan, Lakhani Sunil R, Simpson Peter |
RASAL1 and ROS1 Gene Variants in Hereditary Breast Cancer. Cancers 2020 Sep 12 (9): . Isidori Federica, Bozzarelli Isotta, Ferrari Simona, Godino Lea, Innella Giovanni, Turchetti Daniela, Bonora Ele |
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy. Breast cancer research and treatment 2020 Jul . Li Kai, Liao Ning, Chen Bo, Zhang Guochun, Wang Yulei, Guo Liping, Wei Guangnan, Jia Minghan, Wen Lingzhu, Ren Chongyang, Cao Li, Mok Hsiaopei, Li Cheukfai, Lin Jiali, Chen Xiaoqing, Zhang Zhou, Hou Ting, Li Min, Liu Jing, Balch Charles M, Liao Ni |
Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population. Annals of medicine 2021 Dec 53 (1): 1358-1369. Wang Liye, Zhai Qinglian, Lu Qianyi, Lee Kaping, Zheng Qiufan, Hong Ruoxi, Wang Shus |
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations. Cancer research and treatment 2021 5 54 (1): 30-39. Choi Yoon Ji, Choi Jung Yoon, Kim Ju Won, Lim Ah Reum, Lee Youngwoo, Chang Won Jin, Lee Soohyeon, Sung Jae Sook, Chung Hee-Joon, Lee Jong Won, Kang Eun Joo, Kim Jung Sun, Lim Taekyu, Kim Hye Sook, Kim Yu Jung, Ahn Mi Sun, Kim Young Saing, Park Ji Hyun, Lim Seungtaek, Cho Sung Shim, Cho Jang Ho, Shin Sang Won, Park Kyong Hwa, Kim Yeul Ho |
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data. Oncoimmunology 2021 2 10 (1): 1865653. Dudnik Elizabeth, Moskovitz Mor, Rottenberg Yakir, Lobachov Anastasiya, Mandelboim Rinat, Shochat Tzippy, Urban Damien, Wollner Mira, Nechushtan Hovav, Rotem Ofer, Zer Alona, Daher Sameh, Bar Jair, |
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer treatment and research communications 2022 Aug 33 100623. Bridgewater John, Jiao Xiaolong, Parimi Mounika, Flach Clare, Stratford Jeran, Kamburov Atanas, Schmitz Arndt A, Zong Jihong, Reeves John A, Keating Karen, Bruno Amanda, Fellous Marc, Pereira Mariana Buongermino, Bazhenova Lyudmi |
Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer. Genes 2022 Jul 13 (8): . Zografos Eleni, Andrikopoulou Angeliki, Papatheodoridi Alkistis Maria, Kaparelou Maria, Bletsa Garyfalia, Liontos Michalis, Dimopoulos Meletios-Athanasios, Zagouri Flo |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: